Annette Veltmar joined Amgen Germany as Executive Director Business Unit Hematology/Oncology in March 2013. She has profound knowledge of the Pharmaceutical Industry with a focus on strategy, commercialization and business development in the specialty care (mostly Oncology) area. Prior to joining Amgen, Annette work 8 years for AstraZeneca in various roles at local (Swiss), regional (EU out of Brussels, Belgium) and global (out of London, UK) level, such as Business Director Europe, Global Fast Forward Program Head and Business Unit Head Specialty Care.

Prior to AstraZeneca, Annette was Principle at the Boston Consulting Group where she gained experience in R&D and marketing (incl. launch) strategies, sales force effectiveness and organizational/change management. She started her carrier at Bristol-Myers Squibb Germany in the Medical department.

Annette holds a Master in Pharmacy and PhD in Pharmacology of the University of Heidelberg as well as Master of Business Administration of Insead, Fontainebleau/France. She speaks fluent English, French and German as well as basic Spanish. Her hobbies comprise her family, sports and travelling.

Dr. Werner Föller ist seit dem Jahr 2000 bei Shire und leitet die Geschäfte in der Region Deutschland, Österreich und Schweiz (DACH). Er ist seit über 25 Jahren in der Pharmazeutischen Industrie und im Bereich seltener Erkrankungen tätig.

Nach seinen Anfängen beim Pharmaunternehmen KabiVitrum, wo er verschiedene Medical Affairs-, Marketing- und Vertriebspositionen innehatte, arbeitete Dr. Föller für das biopharmazeutische Start-Up Transkaryotic Therapies (TKT). Die TKT hatte ihren Schwerpunkt auf hochinnovativen biotechnologischen Verfahren für die Entwicklung und Produktion von Therapien für seltene Erkrankungen. Dr. Föller verantwortete hier die Geschäfte in Deutschland und Österreich.

Nachdem TKT in Shire aufgegangen war, leitete Dr. Föller als Vice President und Geschäftsführer die Shire Deutschland GmbH in Berlin. Im November 2013 wurde ihm darüber hinaus die Verantwortung für das Geschäft von Shire in der D.A.CH.-Region übertragen, die er bis heute als Geschäftsführer innehat. Dr. Werner Föller hat an der Universität Karlsruhe in Biologie mit einem neurobiologischen Thema promoviert.

Christoph is a Senior Principal and the Analytics & Local Consulting Lead for Germany and Austria. Christoph joined IMS Health in February 2011 and has experience in pharma/ diagnostics marketing and sales consulting and a solid understanding of strategy development and management consulting.
Prior to joining IMS Health, he worked 10 years at Roche Diagnostics in different management functions in Marketing and Business Development, focusing on topics such as marketing and strategic planning, portfolio and launch management, commercial affairs as well as partnering (mainly lab diagnostics).

Prior to that, Christoph worked 5 years as project manager for Arthur D. Little supporting pharma customers in product strategy development and re-organization

Christoph holds a European Business Administration degree from the University of Hertfordshire. He speaks fluent English, Spanish and German.

Cord is a seasoned executive with a broad understanding of the global Life Science and Healthcare markets. Cord developed technology and market products ranging from instruments over software & IT to assays, biomarkers and genetic consulting services. Before joining Merck in August 2015, Cord was Chief Technology Officer & Member of the Executive Committee at Siemens Healthcare. Before Siemens Cord was a serial Entrepreneur in Europe and the United States, leading as CEO all stages of a venture-backed business from initial start-up to market launch and expansion in Europe, USA and Asia – going thru growth and crisis with Financing, IPO and M&A.

Cord has a Bachelor’s Degree in Engineering from University of Karlsruhe and a Master’s in Theoretical Mechanical Engineering from the University of Siegen. Cord is the inventor of more than 50 patent families and patent applications, and is a published author on subjects ranging from production automation via analytical instruments to assays and biomarkers. He is currently based in Darmstadt, Germany.